BTK and neoplasm: MALT1 KO, but not CARD11 KO, was able to dramatically diminish the tumor growth and dissemination in vitro and in vivo in the resistant MCL cells, supporting our notion that MALT1 hyperactivity critically contributes to IBN resistance via bypassing BTK/CARD11 upstream signaling.